LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
15,918,221
Share change
-191,652
Total reported value
$279,081,656
Put/Call ratio
95%
Price per share
$17.53
Number of holders
62
Value change
-$5,685,317
Number of buys
29
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q4 2016

As of 31 Dec 2016, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,918,221 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Allianz Asset Management GmbH, and BlackRock Fund Advisors. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.